Taken together, our data underline the role of IL-1β as a hub of inflammatory signaling within the tumor microenvironment that drives the tumor-promoting crosstalk between GBM and adaptive immune cells, and thus promotes GBM aggressiveness. This evidence concerns the gene IL1B and glioblastoma.